Zacks upgrades Mazor Robotics to ‘buy’ rating — 5 facts

Zacks upgraded Caesarea, Israel-based Mazor Robotics to a “buy” rating, according to Dakota Financial News.

Advertisement

Here are five facts:

 

1. Zacks has a $10 price target on the company’s stock.

 

2. Mazor traded down .89 percent on Dec. 14, and exchanged 128,021 of the shares.

 

3. With a 50-day moving average of $10.15, Mazor has a 200-day moving average of $12.18.

 

4. The company has a 52-week low of $8.50 and a 52-week high of $14.99.

 

5. Mazor’s market cap hit $188.14 million.

 

More articles on devices:
Grab some rays — Active individuals may need to maintain higher vitamin D levels to minimize stress fracture risk
Houston Methodis Hospital implements CT-free robotic surgery — 5 key points
OrthoSensor raises $3.9M in funding: 5 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.